Esperite N.V. (Euronext: ESP, 'Esperite') announces it is convening an extraordinary general meeting of Shareholders ("EGM") to be held on Wednesday 23 December 2015 to approve its new share option scheme.
The EGM's convocation notice, agenda and the explanatory notes to the agenda are available free of charge at Esperite's offices in Zutphen, the Netherlands and can be downloaded from Esperite's website, www.esperite.com.
About ESPERITE
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.
To learn more about ESPERITE Group, or to book an interview with CEO Frederic Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com and www.genoma.com.
